Prana Biotechnology Ltd
(NASDAQ:PRAN)|
1.79 -0.17 (-8.67%) 2:43ET Delayed |
|
|
|
- Compare PRAN with:
- View: Line | Candlestick
Company Profile
Prana Biotechnology Ltd
Level 2,369 Royal Parade
Victoria, 3052
Australia - Map
Phone: 61 393494906
Fax: 61 393480377
Website: www.pranabio.com
CEO: Geoffrey Paul Kempler
Employees: 13
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Development of our pharmaceutical products
The Company is engaged in the development therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.
Recent news for PRAN
-
Prana Provides Update on Research and Development Programs at AGM
Marketwire - 6 hours ago
-
Prana's Compound Featured in Annals of Neurology
PR Newswire - Nov 18 at 8:30 ET
-
Prana to Present at Rodman & Renshaw 10th Annual Healthcare Conference
Marketwire - Oct 28 at 10:08 ET
-
PRANA BIOTECHNOLOGY LTD Financials
EDGAR Online Financials - Oct 01 at 8:04 ET
-
Prana Announces Filing of Annual Report, Dated September 25, 2008
Marketwire - Sep 29 at 7:00 ET
-
Prana Biotech upgraded by Rodman & Renshaw
Briefing.com - Sep 09 at 5:19 ET
-
The Lancet Neurology Publishes Clinical Results of PBT2 in Alzheimer's Disease Patients
Marketwire - Jul 29 at 1:30 ET
-
Prana Biotechnology Announces Conference Call Following ICAD Presentations
Marketwire - Jul 22 at 2:31 ET
-
Prana Selected for "Hot Topics" and Alzheimer's Association Press Briefing at ICAD
Marketwire - Jul 17 at 7:30 ET
-
Neuron to Publish Prana's PBT2 Preclinical Research
Marketwire - Jul 09 at 12:08 ET